Combination Asthma Inhalers Lower Risk
For most people with asthma, inhaled steroids are the treatment of choice, and highly effective in preventing and controlling asthma symptoms. But some people are not able to achieve adequate asthma control even with consistent use of daily (or twice daily) inhaled steroids. This is most common in cases of severe persistent asthma.In these cases, […]
Study Analyzed Long-term Symbicort® Use In Children With Persistent Asthma
A new study analyzed long-term use of the maintenance combination asthma therapy, SYMBICORT® (budesonide/formoterol fumarate dihydrate), in treating persistent asthma in children 6 to 11 years old. The study examined the safety of SYMBICORT in children for 26 weeks and also included efficacy measures. For children previously treated with inhaled corticosteroid, either alone or in […]
Aerocrine Soars Most Ever on FDA Approval for Asthma Treatment
By Jakob Lindstroem
March 4 (Bloomberg) — Aerocrine AB, the Swedish developer of airway inflammation detection equipment, surged the most ever in Stockholm trading after gaining approval to sell an asthma product in the U.S.
Aerocrine rose as much as 11.4 kronor, or 84 percent, to 25 kronor, and traded at 24.5 kronor as of 10:28 a.m. […]
